Myocardial infarction 1

Common Name(s)

Myocardial infarction 1

Description for this condition is not yet available.
 

Advocacy and Support Organizations

 

Condition Specific Organizations

Following organizations serve the condition "Myocardial infarction 1" for support, advocacy or research.

There are currently no organizations listed in Disease InfoSearch that support this condition. Create a listing.

 

 

General Support Organizations

Not finding the support you need? Show General Support Organizations

 
 
Top

How do you compare to others with this condition?

Privately answer questions about your health. Let resources, you select, come to you.

Anonymously share and see how your answers compare with others with this condition while privately providing key pieces of information to medical researchers, disease advocacy groups, and others ONLY YOU select to help speed up cures and better alternatives.

 
 

Advocacy and Support Organizations

 

Condition Specific Organizations

Following organizations serve the condition "Myocardial infarction 1" for support, advocacy or research.

There are currently no organizations listed in Disease InfoSearch that support this condition. Create a listing.

 

 

General Support Organizations

Not finding the support you need? Show General Support Organizations

 
 
 
 
Top

Scientific Literature

Articles from the PubMed Database

Research articles describe the outcome of a single study. They are the published results of original research.
The terms "Myocardial infarction 1" returned 209 free, full-text research articles on human participants. First 3 results:

Association between angiotensin II type 1 receptor polymorphism and sudden cardiac death in myocardial infarction.
 

Author(s): Peter Kruzliak, Gabriela Kovacova, Olga Pechanova, Stefan Balogh

Journal: Dis. Markers. 2013 ;35(5):287-93.

 

The renin-angiotensin system is involved in the pathogenesis of coronary artery disease and myocardial infarction (MI). Angiotensin II (Ang II) has many adverse effects such as vasoconstriction and vascular remodeling, and these actions are mediated by the angiotensin II type 1 receptor (AT1R).

Last Updated: 29 Oct 2013

Go To URL
Thromboxane A(2) generation, in the absence of platelet COX-1 activity, in patients with and without atherothrombotic myocardial infarction.
 

Author(s): Andrew P DeFilippis, Oluwasegun S Oloyede, Efstathia Andrikopoulou, Amy K Saenger, Joel M Palachuvattil, Yetunde A Fasoro, Eliseo Guallar, Roger S Blumenthal, Thomas S Kickler, Allan S Jaffe, Gary Gerstenblith, Steven P Schulman, Jeffrey J Rade

Journal: Circ. J.. 2013 ;77(11):2786-92.

 

Aspirin's therapeutic action is via inhibition of platelet cyclooxygenase 1 (COX-1) thromboxane A2 (TxA2) production. The aim of this study was to evaluate TxA2 production, in the absence of platelet COX-1 activity, in coronary atherosclerotic heart disease patients with and without ...

Last Updated: 28 Oct 2013

Go To URL
Interleukin-33, matrix metalloproteinase-9, and tissue inhibitor [corrected] of matrix metalloproteinase-1 in myocardial infarction.
 

Author(s): Savas Guzel, Ozden Serin, Eda Celik Guzel, Banu Buyuk, Güzin Yılmaz, Guvenc Güvenen

Journal: Korean J. Intern. Med.. 2013 Mar;28(2):165-73.

 

Acute coronary syndrome (ACS) is characterized by increased inflammatory processes and endothelial activation. We investigated the association between ACS and inflammatory mediators and matrix-degrading enzymes.

Last Updated: 25 Mar 2013

Go To URL

Reviews from the PubMed Database

Review articles summarize what is currently known about a disease. They discuss research previously published by others.
The terms "Myocardial infarction 1" returned 6 free, full-text review articles on human participants. First 3 results:

Natriuretic peptides as an adjunctive treatment for acute myocardial infarction: insights from the meta-analysis of 1,389 patients from 20 trials.
 

Author(s): Ting Lyu, Yichao Zhao, Tuo Zhang, Wen Zhou, Fan Yang, Heng Ge, Song Ding, Jun Pu, Ben He

Journal: Int Heart J. 2014 ;55(1):8-16.

 

Animal studies have reported a cardioprotective effect for atrial natriuretic peptide (ANP) or brain natriuretic peptide (BNP) administration in the setting of acute myocardial infarction (AMI). However, previous trials performed on AMI patients have reported differences in the cardiac ...

Last Updated: 13 Feb 2014

Go To URL
Advances in insulin like growth factor binding protein 1 in the prognosis of acute myocardial infarction.
 

Author(s): Lu Hui, Pan Hui, Gong Feng-ying

Journal: Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2011 Feb;33(1):22-4.

 

Insulin-like growth factor (IGF) is closely associated with cardiovascular diseases. Low IGF-I level and high insulin-like growth factor binding protein-1 (IGFBP-1) level in serum can be used as a marker in predicting the long term morbidity and mortality of acute myocardial infarction ...

Last Updated: 7 Mar 2011

Go To URL
Contemporary treatment of unstable angina and non-ST-segment-elevation myocardial infarction (part 1).
 

Author(s): Shehzad Sami, James T Willerson

Journal: Tex Heart Inst J. 2010 ;37(2):141-8.

 

In this, the 1st part of a 2-part review, we discuss how plaque rupture is the most common underlying pathophysiologic cause of unstable angina and non-ST-segment-elevation myocardial infarction and how early risk stratification is vital in the timely diagnosis and treatment of acute ...

Last Updated: 19 Apr 2010

Go To URL
 
 
Top

Symptoms, Diagnosis, and Treatment

There are currently no related results available in GeneReviews.

 
 
Top

Clinical Trial Information This information is provided by ClinicalTrials.gov

GLP-1 Loading During Elective Percutaneous Coronary Intervention
 

Status: Not yet recruiting

Condition Summary: Angina Pectoris; Myocardial Infarction; Reperfusion Injury; Coronary Heart Disease

 

Last Updated: 29 Apr 2014

Go to URL
IL-1 Blockade in Acute Myocardial Infarction (VCU-ART3)
 

Status: Recruiting

Condition Summary: Acute Myocardial Infarction

 

Last Updated: 19 Aug 2014

Go to URL
Evaluation of the Safety and Efficacy of Using Insulin-like Growth Factor-1 in Patients With a Heart Attack
 

Status: Recruiting

Condition Summary: Heart Failure; Myocardial Infarction

 

Last Updated: 6 Mar 2013

Go to URL